Enapotamab vedotin
Product Specifications
CAS Number
1912424-97-5
Target
Antibody-Drug Conjugates (ADCs) |||TAM Receptor
Related Pathways
Tyrosine Kinase/Adaptors|||Antibody-drug Conjugate/ADC Related
Purity
>95.0%
Bioactivity
Enapotamab vedotin is an investigational antibody-drug conjugate (ADC) specifically targeting the receptor tyrosine kinase AXL. it consists of a monoclonal antibody linked to the potent microtubule-disrupting agent monomethyl auristatin E (MMAE) and demonstrates significant inhibitory potential against high AXL-expressing non-small cell lung cancer (NSCLC), including tumors with resistance to EGFR inhibitors like Osimertinib.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
